XML 34 R19.htm IDEA: XBRL DOCUMENT v3.26.3
DERIVATIVE FINANCIAL INSTRUMENTS
12 Months Ended
Sep. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS DERIVATIVE FINANCIAL INSTRUMENTS
At September 30, 2026, the Company’s derivative instruments, none of which were designated as hedging instruments under Accounting Standards Codification (“ASC”) Topic 815, “Derivatives and Hedging,” consisted of commodity futures, options, and swap contracts which relate to inputs that generally will be utilized within the next twelve months. The notional amounts of the commodity contracts were $154.2 and $136.6 at September 30, 2026 and 2025, respectively.
The following table presents the balance sheet location and fair value of the Company’s commodity contracts. The Company does not offset derivative assets and liabilities within the Consolidated Balance Sheets.
September 30,
20262025
Prepaid expenses and other current assets$20.6 $— 
Other current liabilities0.5 12.6 
The following table presents the Company’s commodity derivative (gains) losses, which were recorded in “Cost of goods sold” in the Consolidated Statements of Operations.
Year Ended September 30,
202620252024
Unrealized (gain) loss on derivatives$(32.7)$15.2 $(2.4)
Realized (gain) loss on derivatives(11.9)2.9 4.5 
Total (gain) loss on derivatives$(44.6)$18.1 $2.1 
The Company is required to maintain cash margin accounts with clearing brokers in connection with its exchange-traded commodity derivative instruments. As of September 30, 2026 and September 30, 2025, the Company had received cash collateral from counterparties of $10.0 and zero, respectively, which was recorded within “Other current liabilities” on the Consolidated Balance Sheets. As of September 30, 2026 and September 30, 2025, the Company had posted cash collateral to counterparties of $0.6 and $17.3, respectively, which was recorded as “Restricted cash” on the Consolidated Balance Sheets.